| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033429862 |
| P356 | DOI | 10.1097/01.MP.0000095782.79895.E2 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0893395222046919?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0893395222046919?httpAccept=text/xml | ||
| https://www.nature.com/articles/3880891.pdf | ||
| P698 | PubMed publication ID | 14614048 |
| P5875 | ResearchGate publication ID | 9012152 |
| P2093 | author name string | Saraswati Sukumar | |
| Mary Jo Fackler | |||
| Douglas P. Clark | |||
| Lauren E. Laitala | |||
| Patricia M. Alli | |||
| Robert T. Pu | |||
| P2860 | cites work | Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression | Q24291194 |
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis | Q27777799 | ||
| Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer | Q28345689 | ||
| Quantitative assessment of promoter hypermethylation during breast cancer development | Q30811494 | ||
| Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. | Q30884723 | ||
| Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer. | Q34334842 | ||
| Detection of DNA methylation. Potential applications to diagnostic cytopathology | Q35103117 | ||
| High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer | Q35759154 | ||
| The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis | Q36313089 | ||
| Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer | Q36648901 | ||
| Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues | Q40657562 | ||
| Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells | Q40891228 | ||
| Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells | Q41070371 | ||
| Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers | Q43578083 | ||
| Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. | Q43583310 | ||
| The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas | Q43655920 | ||
| Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells | Q43973211 | ||
| Cyclin D2 expression in familial and sporadic breast cancer | Q44175923 | ||
| Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. | Q53409752 | ||
| Methylation of the BRCA1 gene in sporadic breast cancer | Q57390855 | ||
| Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas | Q57890923 | ||
| Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers | Q71729088 | ||
| E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas | Q71804951 | ||
| Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation | Q73715187 | ||
| Promoter hypermethylation--can this change alone ever designate true tumor suppressor gene function? | Q73828769 | ||
| Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR | Q73852496 | ||
| Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients | Q78794145 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA methylation | Q874745 |
| cytopathology | Q1881849 | ||
| P304 | page(s) | 1095-1101 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Modern Pathology | Q15724578 |
| P1476 | title | Methylation profiling of benign and malignant breast lesions and its application to cytopathology | |
| Methylation Profiling of Benign and Malignant Breast Lesions and Its Application to Cytopathology | |||
| P478 | volume | 16 |
| Q37582122 | Aberrant promoter methylation of cancer-related genes in human breast cancer |
| Q36753505 | Applications of molecular techniques to fine-needle aspiration biopsy |
| Q38052925 | Biomarkers in the diagnosis of primary and recurrent breast cancer |
| Q35636561 | Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression |
| Q34547465 | Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study |
| Q37800447 | Core needle biopsy versus fine needle aspiration biopsy in breast--a historical perspective and opportunities in the modern era. |
| Q37261842 | CpG methylation analysis--current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology. |
| Q36998647 | DNA methylation in ductal carcinoma in situ of the breast |
| Q96340779 | DNA methylation patterns of RAR-β2 and RASSF1A gene promoters in FNAB samples from Greek population with benign or malignant breast lesions |
| Q34095995 | Epigenetic Signatures in Breast Cancer: Clinical Perspective |
| Q37024069 | Epigenetic regulation as a new target for breast cancer therapy |
| Q36449057 | Epigenetics as a therapeutic target in breast cancer |
| Q46128826 | High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions. |
| Q34960376 | Hypermethylation of CCND2 May Reflect a Smoking-Induced Precancerous Change in the Lung |
| Q38778524 | Incorporating Biomarkers in Studies of Chemoprevention |
| Q35050475 | Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort |
| Q38431295 | Methylation profiling of mesothelioma using real-time methylation-specific PCR: a pilot study. |
| Q91669240 | Promoter Methylation Status of the Retinoic Acid Receptor-Beta 2 Gene in Breast Cancer Patients: A Case Control Study and Systematic Review |
| Q95725159 | Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer |
| Q35801560 | Promoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis |
| Q33911603 | Promoter methylation and the detection of breast cancer |
| Q36100208 | Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids |
| Q36150848 | Targeting epigenetic regulatory mechanisms in cancer chemoprevention |
| Q28069898 | Tumour biomarkers: homeostasis as a novel prognostic indicator |
| Q33570282 | Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis |
Search more.